Predictors of Relapse and Evaluation of the Role of Postoperative Radiation Therapy in a Modern Series of Patients With Surgically Resected Stage III (N2) Non–small Cell Lung Cancer

Advances in Radiation Oncology - United States
doi 10.1016/j.adro.2016.12.004
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Postoperative Radiotherapy for Resected Stage IIIA–N2 Non-Small-Cell Lung Cancer: A Review of Outcomes

Hong Kong Journal of Radiology
Nuclear MedicineRadiologyImaging
2018English

Analysis of Real World Data to Evaluate Survival Benefit of Radiation Therapy in Stage III / N2 Non-Small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

Trimodality Therapy in the Treatment of Stage III N2‐Positive Non‐Small Cell Lung Cancer: A National Cancer Database Analysis

Oncologist
Cancer ResearchMedicineOncology
2020English

Simple OS Risk Score Classification in Resected Pathological Stage IIIA-N2 Non-Small Cell Lung Cancer Patients Before Postoperative Radiotherapy: A Prediction Model

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2019English

P3.01-31 Prognostic Factors in Patients With Resected Pathological N2 Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Use of Hypofractionated Radiation Therapy With Concurrent Chemotherapy in Inoperable Stage II/III Non–small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Choice of Postoperative Radiation for Stage IIIA Pathologic N2 Non-Small Cell Lung Cancer: Impact of Metastatic Lymph Node Number

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2017English

Effects of Postoperative Mediastinal Radiation on Completely Resected Stage II and Stage III Epidermoid Cancer of the Lung

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
1994English

P1.17-14 Outcomes of Hypofractionated Radiation Therapy (HFRT) With Concurrent Chemotherapy in Patients With Stage III Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy